BCG X vs Neurons Lab: full comparison for 2026
Quick verdict
BCG X (4.3/5) edges ahead of Neurons Lab (4.2/5) overall. BCG X is the better choice for enterprises wanting prototypes built during strategy. Neurons Lab is the stronger option for banks and insurers building AI on AWS. The right choice depends on the size of your program, your budget, and whether you want the same firm to build what it recommends.
BCG X vs Neurons Lab: head-to-head summary
| Criterion | BCG X | Neurons Lab |
|---|---|---|
| Founded | 2022 | 2019 |
| HQ | Boston, USA | London, UK |
| Team size | 3,000+ | 50–100 |
| Rating | 4.3 / 5 | 4.2 / 5 |
| Primary differentiator | Builds working prototypes during the strategy phase, with BCG's industry and change practices behind it | Financial-services AI strategy from an AWS Machine Learning Competency partner that builds the prototypes |
| Pricing model | Project fees per engagement; rates not published | Project fees; rates not published |
| Min. engagement | Not disclosed | $100,000+ (Clutch) |
| Primary tech stack | AWS, Azure, Google Cloud | AWS, Amazon Bedrock, Amazon SageMaker |
| Industries served | Financial services, Consumer & retail, Industrial goods, Healthcare, Energy, Public sector | Banking, Insurance, Wealth management, Fintech, Healthcare |
BCG X vs Neurons Lab: overview
BCG X
BCG X launched in 2022, when Boston Consulting Group merged BCG Digital Ventures, BCG Gamma, and BCG Platinion into one unit. Job listings put it at 3,000+ technologists, data scientists, engineers, and designers in more than 80 cities (per company job postings; independently unverifiable). The difference from a pure strategy team is timing. Prototypes get built during planning, so a board can see a working version before it approves the full program. BCG's industry practices and change work back it up, and its fees match BCG's, which keeps most mid-market companies out.
Neurons Lab
Neurons Lab was founded in London in 2019 and has roughly 50 to 100 staff, topped up by a wider network of contract engineers. It is an AWS Advanced Partner with the Machine Learning Competency and works mainly for banks, insurers, and wealth managers. Strategy here means AI discovery and roadmap work that hands straight into prototypes on AWS. Clutch lists a $100,000+ minimum project, high for a firm this size and a sign that it aims at established financial companies.
Services and capabilities: BCG X vs Neurons Lab
| Capability | BCG X | Neurons Lab |
|---|---|---|
| Readiness assessment | ✗ | ✗ |
| Use-case prioritization | ✓ | ✓ |
| TCO / ROI modeling | ✗ | ✗ |
| AI governance & EU AI Act | ✗ | ✓ |
| Build vs. buy advice | ✓ | ✓ |
| Audit of live AI programs | ✗ | ✗ |
| Change management | ✓ | ✗ |
| Can build what it recommends | ✓ | ✓ |
Frameworks and platforms: BCG X vs Neurons Lab
| Framework / platform | BCG X | Neurons Lab |
|---|---|---|
| EU AI Act | N/A | N/A |
| GDPR | N/A | N/A |
| NIST AI RMF | N/A | N/A |
| AWS | ✓ | ✓ |
| Azure | ✓ | N/A |
| Google Cloud | ✓ | N/A |
| Databricks | N/A | N/A |
| Snowflake | N/A | N/A |
Pricing comparison: BCG X vs Neurons Lab
| Criterion | BCG X | Neurons Lab |
|---|---|---|
| Minimum engagement | Not disclosed | $100,000+ (Clutch) |
| Engagement models | Strategy & roadmap engagement, Delivery team | Strategy & roadmap engagement, Delivery team |
| Rate transparency | Not public | Minimum disclosed |
| Price tier | Mid-market | Mid-market |
Target audience comparison: BCG X vs Neurons Lab
| Dimension | BCG X | Neurons Lab |
|---|---|---|
| Best company size | Mid-market to enterprise | Startup to mid-market |
| Best industries | Financial services, Consumer & retail, Industrial goods | Banking, Insurance, Wealth management |
| Best use cases | Testing a new AI-driven product with a working prototype before board approval., Sector-specific AI value cases for a large bank, insurer, or industrial company. | AI roadmaps for a bank or insurer that already runs on AWS., Generative AI assistants for wealth advisers and relationship managers. |
| Typical project type | Strategy & roadmap engagement | Strategy & roadmap engagement |
BCG X vs Neurons Lab: pros and cons
| BCG X | |
|---|---|
| + | Prototypes come out of the strategy phase, so feasibility is tested before the budget is committed |
| + | Draws on BCG's industry practices for sector-specific value cases |
| + | Organization and change work is available from the wider firm |
| + | Designers work next to engineers, which matters when AI changes a customer-facing product |
| - | BCG-level fees keep it out of reach for most mid-market companies |
| - | Strategy and build are sold by the same firm, which can tilt the roadmap toward work BCG X will deliver |
| - | Formed by merging three units in 2022, so ask how strategy and engineering staff are combined on your project |
| Neurons Lab | |
|---|---|
| + | Focus on banks, insurers, and wealth managers means less time explaining regulated-industry basics |
| + | AWS Machine Learning Competency is checked by AWS, so the engineering claim has outside validation |
| + | Discovery work moves into a working prototype quickly |
| + | Senior people do most of the work on a team this small |
| - | A small core team, so large multi-country programs would stretch it |
| - | Closely tied to AWS, which matters if your data lives on Azure or Google Cloud |
| - | A Clutch minimum of $100,000+ is steep for a first strategy engagement |
Who should choose BCG X?
A typical fit: testing a new AI-driven product with a working prototype before board approval.
Builds working prototypes during the strategy phase, with BCG's industry and change practices behind it. Minimum engagement is not publicly disclosed. Works best with clients in Financial services, Consumer & retail, Industrial goods, Healthcare, Energy, Public sector.
Who should choose Neurons Lab?
A typical fit: AI roadmaps for a bank or insurer that already runs on AWS.
Financial-services AI strategy from an AWS Machine Learning Competency partner that builds the prototypes. Minimum engagement starts at $100,000+ (Clutch). Works best with clients in Banking, Insurance, Wealth management, Fintech, Healthcare.
Decision matrix: BCG X vs Neurons Lab
| Your situation | Recommended choice |
|---|---|
| Your board wants a costed, sequenced roadmap within a quarter | Neither lists cost modeling; ask for a sample roadmap |
| You already run AI that is missing its targets | Neither offers a separate audit; ask for a scoped review |
| Regulators will ask how each AI system is governed | Neurons Lab |
| AI will change roles and processes for many staff | BCG X |
| You want the strategy firm to build the result too | Both can deliver after the strategy |
| Your budget is at the lower end | Compare: BCG X (Not disclosed) vs Neurons Lab ($100,000+ (Clutch)) |
| You need a large team across many countries | BCG X |
Use case fit: BCG X vs Neurons Lab
| Use case | BCG X fit | Neurons Lab fit | Winner |
|---|---|---|---|
| Testing a new AI-driven product with a working prototype before board approval. | Strong | Limited | BCG X |
| Sector-specific AI value cases for a large bank, insurer, or industrial company. | Strong | Limited | BCG X |
| AI roadmaps for a bank or insurer that already runs on AWS. | Limited | Strong | Neurons Lab |
| Generative AI assistants for wealth advisers and relationship managers. | Limited | Strong | Neurons Lab |
Verdict: BCG X vs Neurons Lab
BCG X (4.3/5) is the stronger overall choice for most AI Strategy Consulting projects. Builds working prototypes during the strategy phase, with BCG's industry and change practices behind it.
Neurons Lab (4.2/5) is worth a look if you need generative AI assistants for wealth advisers and relationship managers. If your situation matches that, Neurons Lab is a competitive option.
Related comparisons
BCG X vs Neurons Lab FAQ
Is BCG X better than Neurons Lab?
BCG X (4.3/5) scores higher overall, but "better" depends on your use case. BCG X's strongest advantage: prototypes come out of the strategy phase, so feasibility is tested before the budget is committed. Neurons Lab's strongest advantage: focus on banks, insurers, and wealth managers means less time explaining regulated-industry basics.
How do BCG X and Neurons Lab differ in pricing?
BCG X's pricing: project fees per engagement; rates not published. Neurons Lab's pricing: project fees; rates not published with a minimum engagement of $100,000+ (Clutch). Any hourly bands shown come from Clutch, not a published rate card, so a scoping call is still needed for a project quote.
Which is better for enterprise: BCG X or Neurons Lab?
BCG X is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each consultant before shortlisting.
What are the main differences between BCG X and Neurons Lab?
BCG X's primary differentiator is: builds working prototypes during the strategy phase, with BCG's industry and change practices behind it. Neurons Lab's primary differentiator is: financial-services AI strategy from an AWS Machine Learning Competency partner that builds the prototypes. They also differ in team size (3,000+ vs 50–100), minimum engagement (Not disclosed vs $100,000+ (Clutch)), and primary industries served (Financial services, Consumer & retail vs Banking, Insurance).
Verify all details directly with each consultant before making a decision.